BioNTech SE
These innovative biotech stocks have a good chance of breaking out in 2025
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and portfolio manager at Emerald Advisors, […]
Read More
Stocks making the biggest moves premarket: Walmart, Lowe’s, Super Micro Computer, BioNTech and more
Check out the companies making headlines in premarket trading. Walmart – The retail giant gained about 4% after posting fiscal third-quarter results that surpassed Wall Street’s estimates. Walmart also boosted its guidance as customers buy more than groceries. Lowe’s — The home improvement retailer’s shares fell 1.7%. Although the company reported a top- and bottom-line […]
Read More
Stocks making the biggest moves after hours: Domino’s Pizza, Ulta, Applied Materials, Palantir and more
Check out the companies making headlines in after-hours trading: Domino’s Pizza , Ulta Beauty — Shares surged about 8% after Berkshire Hathaway announced a new stake in the pizza chain in a regulatory filing. The Warren Buffett-led firm bought more than 1.2 million shares, making the stake worth around $550 million at the end of […]
Read More
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Independent presidential candidate Robert F. Kennedy Jr. makes an announcement on the future of his campaign in Phoenix, Arizona, U.S. August 23, 2024. Thomas Machowicz | Reuters Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human […]
Read More
Stocks making the biggest moves midday: Tesla, Airbnb, Toast, Pinterest & more
Check out the companies making headlines in midday trading. Tesla — The electric vehicle stock gained nearly 7%, continuing to rally on the heels of Donald Trump winning a second presidential term. The Elon Musk-helmed company saw its market capitalization rise to $1 trillion on Friday. Shares have gained more than 26% this week. Trump […]
Read More
Stocks making the biggest moves premarket: Pinterest, Monster Beverage, Bath & Body Works, Trump Media & more
Check out the companies making headlines before the bell. Trump Media & Technology Group — Shares of President-elect Donald Trump’s media company fell another 4.6% in premarket trading following a 23% plunge in the previous session. The stock, which trades under ticker Trump’s initials, DJT, has given up Wednesday’s rally triggered by Trump’s election victory. […]
Read More
Stocks making the biggest moves midday: Visa, Smartsheet, JD.com and more
Check out the companies making headlines in midday trading: Visa — Shares dropped nearly 4% following a Bloomberg report that the Justice Department is preparing to file an antitrust lawsuit against the credit card network and payments processor. Smartsheet — Shares surged more than 6% after Blackstone and Vista Equity Partners agreed to buy the […]
Read More
Stocks making the biggest moves premarket: Visa, Starbucks, Salesforce, Lowe’s and more
Check out the companies making headlines in premarket trading: Thor Industries — Shares dropped 2% after the RV maker issued disappointing fiscal-year earnings guidance. The company expects earnings per share to range between $4 and $5, well below a StreetAccount estimate of $6.27 per share. Arlo Technologies — The security systems company popped 3% after […]
Read More
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
New vaccine COMIRNATY® (Covid-19 Vaccine, mRNA) by Pfizer, available at CVS Pharmacy in Eagle Rock, California. Irfan Khan | Los Angeles Times | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! […]
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025. The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 […]
Read More